Illumina unveils 18-month NovaSeq X roadmap targeting Q70 quality and 35B reads output

Reuters02-23 22:15
<a href="https://laohu8.com/S/ILMN">Illumina</a> unveils 18-month NovaSeq X roadmap targeting Q70 quality and 35B reads output

Illumina Inc. announced an 18-month roadmap of updates for its NovaSeq X systems, including plans to introduce Q70 quality score technology and increase output from 25 billion reads to 35 billion reads (up 40%), and from 10 billion reads to 14 billion reads. The company said it expects faster turnaround times, with 14 billion reads in 20–22 hours, representing an average 30% improvement in speed on whole-genome sequencing workflows. Illumina also said new flow cells, staggered starts, software enhancements, and DRAGEN pipeline advances will be rolled out across its installed base of 890 NovaSeq X systems globally.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602230915PR_NEWS_USPR_____LA92796) on February 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment